Recent Updates — ICLR
ICON plc issued $2.15 billion of senior unsecured notes, comprising $500 million at 5.064% due 2029, $1.0 billion at 5.421% due 2031, and $650 million at 5.995% due 2036. The company used the net proceeds to repay a $900 million senior secured term loan, redeem $750 million of May 2027 notes, and retire a $500 million bridge facility. This refinancing triggered a $12.2 million loss on extinguishment of debt and released collateral securing other borrowings. Separately, the board increased the share repurchase authorization to $750 million following $400 million in buybacks during the third quarter. ICON plc is a global contract research organization providing outsourced clinical development services.
ICON plc reported third-quarter revenue of $2,024.8 million and adjusted diluted earnings per share of $2.66, a 17% decline from the prior year period but an increase over Q2 2026. The company generated free cash flow of $302.4 million and repurchased $400 million in shares at an average price of $170 per share. Net business wins totaled $3,150 million with a book-to-bill ratio of 1.56x, while the closing backlog reached $24.5 billion. Management updated full-year guidance to expect revenue between $8,100 and $8,200 million and adjusted diluted EPS in the range of $10.35 to $10.65. The Board increased the share repurchase authorization by $350 million, bringing the total available for buybacks to $750 million. ICON plc is a world-leading clinical research organization providing integrated consulting, clinical development, and commercialization solutions.
ICON plc announced it will report financial results for the third quarter of 2026 after market close on Tuesday, October 27, 2026. A conference call and webcast to discuss performance are scheduled for Wednesday, October 28, 2026, at 8:00 am ET. The company operates as a world-leading clinical research organization providing integrated consulting, clinical development, commercialization, and post-marketing solutions globally.
On August 13, 2026, ICON Investments Six Designated Activity Company, a wholly-owned subsidiary of ICON plc, issued $2.15 billion in senior unsecured notes consisting of $500 million of 5.064% Notes due 2029, $1.0 billion of 5.421% Notes due 2031, and $650 million of 5.995% Notes due 2036. ICON plc provided a senior unsecured guarantee for the issuance. The net proceeds were used to repay all outstanding term loans under the senior secured term loan facility on August 13, redeem the outstanding 5.809% Senior Secured Notes due 2027 on August 14, and repay borrowings under the bridge facility credit agreement on August 17. Consequently, collateral securing the revolving credit facility and subsidiary guarantees under existing notes were released. ICON plc operates in the clinical research organization industry.